https://www.business-standard.com/article/international/researchers-find-effective-drug-to-treat-autoimmune-itp-blood-disorder-122121100505_1.html
0
0
12/11/22 at 12:14pm
Organization
Business Standard
Author
ANI
41 words
0
Comments
According to findings from the ADVANCE IV clinical trial patients taking efgartigimod a medication being studied for use to treat chronic primary ITP showed greater improvement in platelet counts
You are the first to view
Create an account
or login to join the discussion